Rare diseases
Investigational molecules
Locations
Back to Lithuania16 clinical trials in Panevezys, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
LithuaniaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
LithuaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
LithuaniaStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
LithuaniaEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
LithuaniaStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
LithuaniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
LithuaniaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
LithuaniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
LithuaniaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
LithuaniaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on ulcerative colitis treatments, investigating novel therapeutic approaches including mirikizumab, etrasimod, and VTX002 for patients with moderate to severe conditions.
Additional research includes studies on Crohn's Disease with targeted therapeutic approaches.
Comprehensive research into atherosclerotic cardiovascular disease prevention and treatment, including trials of inclisiran for reducing major adverse cardiovascular events.
Studies include both primary prevention and management of established cardiovascular conditions.
Innovative studies examining treatments for heart failure with reduced ejection fraction and acute cardiac conditions, including investigation of tovinontrine and selatogrel.
Focus on both immediate intervention and long-term cardiac health improvement.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
